SAN DIEGO, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Cue Health Inc. (Cue) announced today that, as of November 9, the U.S. Department of Health and Human Services (HHS) began deploying its molecular, ...

Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively engage and modulate disease-specific T cells for the ...

For the third NBA season in a row, Cue Health is hoping to lead the league in assists as its go-to COVID-19 testing company. The NBA has tapped Cue to serve as its official provider of at-home and ...

Cue Biopharma is a biotech focused on developing immunogenic peptides to fight specific diseases, particularly cancers. CUE's most advanced project, CUE-101, has shown favorable early results in a ...

There have been two separate times, over the last six months, when my son has had a cold, now more commonly referred to as COVID-19 symptoms. We dropped everything to get him tested both times, and ...

SAN DIEGO--(BUSINESS WIRE)--Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United States Food and Drug ...